Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028287 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-04 | 2024-12-02 | PTCT | ZELDIS JEROME B | Dir | M - OptEx | $40.93 | +24.0K | 26.5K | +960% | +$982.3K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | ZELDIS JEROME B | Dir | S - Sale+OE | $51.50 | -24.0K | 14.5K | -62% | -$1.24M |
| DM | 2024-12-04 | 2024-12-02 | PTCT | ZELDIS JEROME B | Dir | M - OptEx | $0.00 | -24.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | M | A | 12,000 | $30.86 | 26,500 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-02 | S | D | 3,667 | $52.39 | 14,500 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.02 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-12-02 | S | D | 2,634 | $51.43 | 18,167 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.00 to $51.86 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-12-02 | S | D | 5,699 | $50.52 | 20,801 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to 50.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-12-02 | S | D | 8,813 | $51.44 | 17,687 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.10 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2024-12-02 | S | D | 3,187 | $52.42 | 14,500 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.10 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2024-12-02 | M | A | 12,000 | $51.00 | 26,500 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 12,000 | $0.00 | 0 | D | $30.86 · — to 2026-01-03 | 12,000 Common Stock | (F7) Currently exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 12,000 | $0.00 | 0 | D | $51.00 · — to 2025-01-02 | 12,000 Common Stock | (F7) Currently exercisable. |